 |
|
 |
 |
 |
 |
 |
|
|
 |
||||||||||||||||||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||||||||||||||||||||
| Home > WorldWIDE slide resource | |
 |
|
WorldWIDE slide resource |
New Concepts in the Management of Type 2 Diabetes: A DDP-4 Inhibitor Pre-symposium
World Congress on Controversies in Obesity, Diabetes and Hypertension (CODHy) Satellite Pre-symposium, October 2006
Introduction and Overview: Key Limitations in the Current Therapies for Type 2 Diabetes
Dysregulation of Insulin and Glucagon in the Pathogenesis of Type 2 Diabetes
The Emerging Role of Incretin-related Therapy in the Management of Type 2 Diabetes
This symposium was supported by an unrestricted educational grant from Merck & Co., Inc. (Merck Sharp & Dohme).
 |
|
|
|
|
 |
|
|
||
 |
||
|
|
|
|
 |
|
|
||
 |
||
 |
|
Print this page |
|
||
 |
Add to Favourites |
|
|